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Abstract
Ultrasound cavitation of microbubble contrast agents has a potential for therapeutic applications
such as sonothrombolysis (STL) in acute ischemic stroke. For safety, efficacy, and reproducibility
of treatment, it is critical to evaluate the cavitation state (moderate oscillations, stable cavitation,
and inertial cavitation) and activity level in and around a treatment area. Acoustic passive
cavitation detectors (PCDs) have been used to this end but do not provide spatial information.
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This paper presents a prototype of a 2-D cavitation imager capable of producing images of the
dominant cavitation state and activity level in a region of interest. Similar to PCDs, the cavitation
imaging described here is based on the spectral analysis of the acoustic signal radiated by the
cavitating microbubbles: ultraharmonics of the excitation frequency indicate stable cavitation,
whereas elevated noise bands indicate inertial cavitation; the absence of both indicates moderate
oscillations.
The prototype system is a modified commercially available ultrasound scanner with a sector
imaging probe. The lateral resolution of the system is 1.5 mm at a focal depth of 3 cm, and the
axial resolution is 3 cm for a therapy pulse length of 20 µs. The maximum frame rate of the
prototype is 2 Hz. The system has been used for assessing and mapping the relative importance of
the different cavitation states of a microbubble contrast agent. In vitro (tissue-mimicking flow
phantom) and in vivo (heart, liver, and brain of two swine) results for cavitation states and their
changes as a function of acoustic amplitude are presented.

I. Introduction
Terapeutic uses of microbubble (MB) ultrasound (US) contrast agents are emerging, notably
for drug and gene delivery [1] and sonothrombolysis (STL) [2]. In the context of stroke, the
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addition of US and MBs to standard thombolytic tissue plasminogen activator (tPA) therapy
has been shown to accelerate thrombus dissolution in humans [3]. However, MB cavitation
also has the potential for detrimental side effects under certain circumstances. Tung et al. [4]
documented blood–brain barrier opening in mice at an acoustic peak negative pressure
(PNP) of 0.3 MPa (generating dominant stable cavitation) and red blood cell extravasations
at a PNP of 0.6 MPa (generating dominant inertial cavitation) at 1.5 MHz. These bioeffects
may be dangerous in the presence of the anticoagulant and neurotoxic drug tPA. It is
suspected that, in the presence of tPA, MB-mediated US even at relatively low PNPs (<0.3
MPa) can increase the occurrence rate of symptomatic hemorrhage in humans [5]. In
addition, US and MBs alone (without tPA) have thrombolytic effects, as demonstrated in
animal studies [6]–[8] and with a limited number of human subjects [9], without
documented significant adverse effects. For the safety and effectiveness of a MB-mediated
US treatment, the ultrasound power in the treatment region must be monitored and
controlled. We hypothesize that the dynamic state of ultrasound-excited MBs in the
treatment region is directly responsible for the therapy outcome and can be controlled by the
local acoustic field. Therefore, it is essential to control and maintain a desirable type and
level of MB cavitation in the treatment area inside the body for all patients. In particular,
based on prior in vitro and in vivo experience, we hypothesized that stable cavitation is an
efficient and safe regime for MB-mediated sonothrombolysis without tPA [8], [10], [11].
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Particularly for MB-mediated US stroke therapy, it is important to adjust the acoustic output
for the compensation of the individual skull attenuation because human skulls exhibit a wide
range of patient-dependent acoustic attenuations [12], [13]. Single-element-transducer-based
passive cavitation detectors (PCDs) have been used for this purpose [4], [14]–[16], but they
do not provide information on the heterogeneous spatial distribution of cavitation activities.
Passive two-dimensional cavitation mapping has been proposed for monitoring localized
cavitation induced by high-intensity focused ultrasound (HIFU) pulses [17], [18], but the
setup had a limited axial resolution because of the asynchrony between the therapy pulses
and the monitoring device.
We developed a prototype STL system capable of therapy guidance and cavitation imaging.
The system is a modified commercial US scanner iE33 with a sector imaging probe S5-1
(Philips Healthcare, Andover, MA). Cavitation imaging is based on the spectral analysis of
acoustic signals radiated by the cavitating microbubbles [4], [19], [20]: ultraharmonics of
the excitation frequency indicate stable cavitation (SC), whereas noise bands indicate
inertial cavitation (IC). The present paper demonstrates the use of the system in vitro and in
vivo.
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II. Methods
A. STL and Cavitation Monitoring System
An iE33 imaging scanner is modified with additional capabilities of image guidance,
sonothrombolysis treatment, therapy monitoring, and cavitation imaging.
1) Image Guidance and Therapy Monitoring—The STL system is capable of B-mode
imaging for locating anatomical landmarks; Doppler and low-mechanical index (MI)
contrast imaging for identifying a vessel occlusion and monitoring recanalization as therapy
progresses, and verifying the presence of MBs in a treatment area before launching the STL
pulse sequence.
2) Acoustic Conditions in STL Treatment Mode—In this mode, ensembles of four
1.6-MHz STL pulses of the same length (to be chosen between 5, 10, 20, or 44 µs) are
transmitted into 19 directions within a 54° sector area. Two 1.7-µs background B-mode
IEEE Trans Ultrason Ferroelectr Freq Control. Author manuscript; available in PMC 2014 January 30.

Vignon et al.

Page 3

NIH-PA Author Manuscript

pulses are interleaved between consecutive ensembles of 4 STL pulses. Additional 1.7-µs Bmode pulses are sent into the rest of a 90° sector. The pulse sequence per frame is depicted
in Fig. 1. The pulse repetition frequency (PRF) is 8 kHz and the frame rate is adjustable up
to 20 Hz. The active aperture of the S5-1 probe is ~2 × 1 cm and the transmit focal depth is
3.2 cm.
3) PNP Calibration—The output amplitude of the ultrasound system is controlled in 0.5dB increments of the driving voltage. In a separate calibration experiment, hydrophone
measurements (diameter 0.2 mm, Precision Acoustics Ltd., Dorchester, UK) of the PNP
were performed at increasing driving voltages of the sonothrombolysis pulses. A 5-cm-thick
tissue mimicking phantom (TMP) with a nominal attenuation of 0.49 dB/MHz/cm was
inserted between the S5-1 probe and the hydrophone. Efforts were made to place the
hydrophone at the lateral peak of PNP at a depth of 6 cm. These measurements are used
throughout the paper to document nominally derated PNPs.
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4) Cavitation Imaging Algorithm—Backscattered RF data are streamed from the
scanner’s signal path via a separate computer workstation through a custom set of additional
RF capture boards. Data processing and display are performed in real-time using Matlab.
The first and second STL pulses within each ensemble of four are first subtracted to
eliminate stationary echo components (as a tissue-suppression step). Only the first and
second pulses are used within each ensemble because each individual pulse induces
significant bubble destruction [21]. The resulting RF data (corresponding to nonstationary
signals, presumably scattered only from cavitating bubbles) is then band-pass filtered at the
first ultraharmonic band (1.5f0, where f0 is the insonation center frequency), the second
harmonic band (2f0), and noise bands (1.25f0 and 1.75f0). The band-pass filters’ bandwidth
is matched to that of the transmit pulse. An additional high-pass filter with cutoff at 1.25f0 is
applied to the tissue-suppressed signal to encompass all cavitation activity signals. For any
given location in the image, if the local ultraharmonic amplitude exceeds the noise
amplitude by at least 3 dB, the corresponding image pixels are colored yellow, indicating
dominant SC. If this is not the case and the noise level is within 10 dB of the second
harmonic level, the corresponding pixels are colored red, indicating dominant IC. If bubble
signals cannot be classified as SC or IC, corresponding pixels are colored green, indicating
dominant moderate oscillations (MO). The brightness is modulated by the intensity of the
high-pass filtered data. If the high-pass filtered data are below the user-defined dynamic
range (always 15 dB in this manuscript), no color is displayed and the background grayscale
B-mode image is displayed with a 40 dB dynamic range. A block diagram of the algorithm
is shown in Fig. 2.
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The average spectrum of the nonstationary RF data over the treatment area or a restricted
region of interest (RO I) is also displayed for qualitative evaluation (in decibel scale, with a
60 dB dynamic range). Examples of the display available to the user during STL treatment
are presented in Figs. 4–5 and 7–9. It is displayed side-to-side (on the workstation’s screen)
with the scanner’s display of the B-mode image of the anatomy. Note that the B-mode
images that underlie the cavitation images presented in this paper are of substantially lower
quality than the standard (commercial) B-mode images produced by the scanner, because of
the use of many fewer A-lines (44 versus 128 to 256 typically) and an incomplete signal and
image processing chain (for speed in Matlab). An instantaneous cavitation dose was also
calculated for each frame: the ultraharmonic and noise doses are the spatial averages of the
ultraharmonic- and noise-filtered images, respectively, and are used as proxies for SC and
IC strengths.

IEEE Trans Ultrason Ferroelectr Freq Control. Author manuscript; available in PMC 2014 January 30.
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The commercially available US contrast agent Definity (Lantheus Medical Imaging, North
Billerica, MA) is employed. The contrast MBs at a concentration of 0.01 mL/L are
circulated in closed loop inside a 6-mm-diameter vessel phantom (model 524, ATS
Laboratories, Bridgeport, CT) at 3 cm depth, using 14-mm-diameter tubing and a peristaltic
pump set at 125 mL/min (Masterflex Digi-staltic model 77200–60, Cole-Parmer, Vernon
Hills, IL). The imaging depth is 6 cm. The imaging rate is 2 Hz, allowing significant
microbubble replenishment between consecutive images. The phantom is insonified
longitudinally with 20-µs pulses, first through a coupling water path, then through the
squama of three thin human temporal bone samples (<2 mm thickness, no trabecular bone
present) to investigate the effects of frequency-dependent attenuation. A schematic of the
experimental setup is presented in Fig. 3. Cavitation images were recorded at 2 Hz at
increasing output MIs: every four frames, the probe’s driving voltage was increased by 1 dB
for an MI range of 0.1 to 1.7.
C. In Vivo Study
Animal studies were approved by the Institutional Animal Care and Use Committee at
University of Nebraska Medical Center (UNMC).
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Two pigs (weight ~35 kg) were anesthetized with isoflurane and ventilated at 10 breaths per
minute. Intravenous (IV) lines were placed for MB infusion. One vial was diluted in 0.9%
normal saline (3% Definity) and infused over 30 min at an average rate of 3 mL/min. The
STL system was synchronized to the animals’ ECG signals (one image every 2 heart beats;
that is, an imaging rate of ~0.8 Hz at 100 heart beats per minute). This allowed sufficient
bubble replenishment for comparable bubble concentrations from image to image in the
main arteries. 20-µs-long STL pulses were used. The imaging depth was 6 cm. Cavitation
images were displayed and recorded at increasing MIs: the scanner’s output voltage was
increased every 4 frames by 1 dB for an MI range of 0.1 to 1.7. For each pig, two data sets
were acquired for three organs: brain (transtemporally), heart (parasternal short-axis view of
the left ventricle), and liver (subcostal view, no respiration gating). The brain and heart
views correspond to views typically used in brain and heart sonothrombolysis studies at
UNMC [8], [11].

III. Results
A. In Vitro Study
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1) Cavitation Imaging—Example cavitation images of the vessel phantom are shown in
Fig. 4 (skull sample not inserted) and Fig. 5 (skull sample inserted under the S5-1 probe).
Spatial information is provided showing cavitation activities confined within the vessel, and
at higher cavitation levels toward the center of the image than at the edges (reflecting angledependent transmission power of the phased array and refraction effects at the skull interface
[22]). Signal smears beyond the vessel boundaries resulting from the poor spatial resolution
(at best 3 cm for a 20-µs pulse length). In both cases (without and with skull), cavitation
imaging allows visualizing the transitions between dominant MO, SC, and IC as pulse
amplitude is increased. Notice that in this particular case, no strong frequency-dependent
attenuation effects (as would be expected when transmitting ultrasound through skull) are
observed; this may be due to the thinness of this particular bone sample (<2 mm of cortical
bone).
2) Dose Monitoring and Skull Attenuation—By displaying the average spectrum of
the backscattered signal over a region of interest as a function of MI, the user can visualize
at which MIs dominant SC and dominant IC occur. Fig. 6 (left) shows the spectrum
IEEE Trans Ultrason Ferroelectr Freq Control. Author manuscript; available in PMC 2014 January 30.
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evolution as a function of MI through water (top) and through a temporal bone sample
(bottom). In the nonattenuated experiment, salient ultraharmonics (indicating dominant SC)
are clearly seen from MIs ~0.3 to 0.8 and strong noise (indicating dominant IC) occurs from
MIs ~0.8 to 1.5. At higher MIs, both the ultraharmonic and noise responses fade, which may
be indicative of a higher regime of fast bubble destruction. Through the temporal bone
sample, salient ultraharmonics are seen starting at an MI of ~0.9 and no dominant noise can
be seen up to an MI of 1.7.
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It is possible to quantitatively identify the threshold for dominant stable cavitation from the
recorded back-scattered spectra and cavitation doses (Fig. 6, right). The threshold is defined
as the MI value at which the ultraharmonic dose exceeds the noise dose by at least 3 dB,
indicating salient ultraharmonic activity. By comparing the MI threshold for SC through a
skull sample to the threshold through an unattenuated path, it is possible to estimate the
attenuation of the skull sample noninvasively (that is, without the need to use a hydrophone
on the other side of the skull). With a 20-µs pulse length, the SC threshold is measured at MI
= 0.3 through an unattenuated path, and MIs of 0.6, 0.7, and 0.9 through three temporal bone
samples. These values correspond to estimates of 50% to 66% bone attenuation. This is
below reported values in the literature (averaging ~80% attenuation at 2 MHz) [12], [13] but
can be explained by the observed thinness and absence of trabecular bone of the tested
samples, and the lower frequency. The thresholds vary slightly as a function of pulse length,
with longer pulses corresponding to lower MI thresholds [23].
B. In Vivo Study
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1) Cavitation Imaging—In vivo cavitation images of the brain, heart, and liver from one
of the two imaged pigs are shown in Figs. 7, 8, and 9, respectively. In both pigs, cavitation
imaging allowed visualization of the transitions between dominant MO, SC, and IC.
However, the transitions were not as sharp as seen in vitro, so that it was difficult to
establish clear threshold values between cavitation regimes, with the exception of cavitation
within the heart left ventricle. Most of the time, the cavitation image showed a mix of two or
three of the cavitation regimes present at the same time in the treatment area. The image also
varied significantly from one image to the next (i.e., from one cardiac cycle to the next; see
videos), probably because of threshold effects on the changing bubble populations. In the
liver images, respiratory motion was an additional cause of variability. Spatial information is
provided showing dominant cavitation activities confined around major vessels in the brain
and liver and within the ventricle in the heart image. Signal smearing in the axial dimension
was problematic, with signals appearing to originate from beyond the contralateral skull in
the brain images. For the heart, signal smearing from the relatively high-bubbleconcentration areas in the ventricle into the low-bubble-density myocardium make it
virtually impossible to monitor cavitation activities in the myocardium.
2) Dose Monitoring—Fig. 10 (left) displays the back-scattered spectra from the RO I as a
function of MI in the brain (top), heart (middle), and liver (bottom). For a given organ,
similar patterns were observed in both pigs.
Fig. 10 (right) shows the corresponding ultraharmonic and noise doses as a function of MI.
Only in the case of microbubbles in the left ventricle is it possible to reliably identify the SC
threshold (the MI at which the ultraharmonic dose exceeds the noise dose by at least 3 dB) at
an MI of 0.6. The heart is a special case, with a high concentration of freely oscillating
bubbles in the large heart chamber, resulting in a high SNR for cavitation monitoring.

IEEE Trans Ultrason Ferroelectr Freq Control. Author manuscript; available in PMC 2014 January 30.
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An imaging transducer was used to deliver sonothrombolysis pulses and spatially and
temporally monitor the dominant state and activity level of cavitation present in a treatment
area. The system was demonstrated in vitro and in vivo.
Earlier versions of this microbubble cavitation imaging system have been used successfully
to correlate therapeutic safety and efficacy to cavitation state and activity level in in vitro
[10] and in vivo [8], [11] studies. In the absence of tPA, a moderate level of SC was as
effective as IC for in vitro thrombus dissolution [10] but the stronger IC levels seemed to be
required for consistent recanalization in vivo in a pig ischemic brain model [8]. In the
presence of tPA, SC seemed more effective than IC in a cardiac ischemia model [11]. In our
experience, it seems that in the absence of tPA, moderate levels of IC may be more effective
than SC without causing harmful bioeffects [8].
In the future, when the optimal cavitation state and level are firmly established, it is
expected that microbubble cavitation imaging can be used to plan and monitor therapy and
ensure that each patient receives the adequate cavitation dose, adaptively modulating the
ultrasound output power to compensate from patient-dependent skull attenuation effects.
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The 2 Hz frame rate of the cavitation imaging mode is currently suboptimal for cavitation
monitoring but sufficient for treatment planning: acquiring cavitation dose curves as a
function of MI such as those in Fig. 6 and 10 takes less than 1 min. This procedure allows
the user to decide which output MI is required for a desired cavitation state before starting
the actual therapy. Note that 2 Hz, or one image every other heartbeat, seems to be slightly
too fast to allow new bubbles to completely replenish the insonified area in the phantom and
animal experiments, respectively. This would account for the plateau observed in the
cavitation curves at higher MIs.
Cavitation monitoring during STL treatment also allows estimating the rate at which MBs
are destroyed. Post hoc analysis from a pig STL study suggests that at the MIs used in the
study (1.7 and 2.4) most MBs are destroyed in only one frame (50 ms), so that the bubble
duty cycle is, in effect, much shorter than the ultrasound duty cycle [21]. This measurement
tool may enable fine-tuning of pulse sequences according to local bubble replenishment rate
for optimal use of the MBs, e.g., guiding how long to apply the therapeutic impulses.
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Engineering work remains to improve the algorithm for robustness. For example, although
ultraharmonics were clearly seen in vitro and transthoracically in the heart left ventricle in
vivo, their visualization was often problematic in the brain and liver. Possible solutions
include working with a higher MB dose, a more homogeneous MB formulation (different
MB sizes in the field of view may be subjected to different cavitation states and levels under
the same ultrasound excitation), modifying the central frequency for more efficient
generation of SC (because the cavitation state and level as a function of pressure are
frequency-dependent), lowering the central frequency for better transcranial and tissue
penetration, using temporally apodized waveforms to prevent spectral side lobes,
compensating for frequency-dependent effects caused by the transducer bandwidth and skull
and tissue attenuation, and utilizing autoregression analysis or wavelet analysis for more
sensitive spatio-temporal detection of the ultraharmonic component and principal
component analysis for more accurate cavitation state classification. Finally, the greenyellow-red display of cavitation intensities relies on user-defined thresholds and results in
discontinuities in the image. Classifying a given pixel inside one of three cavitation regimes
is also not representative of the reality of a cavitation field in which several cavitation states
usually exist simultaneously in proximity because of a wide distribution of bubble sizes,

IEEE Trans Ultrason Ferroelectr Freq Control. Author manuscript; available in PMC 2014 January 30.
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bubble environment (e.g., within a capillary versus within a large artery), and spatially
heterogeneous acoustic field. Other display solutions thus remain to be investigated. For
example, it may be a better alternative to display separate SC or IC probability maps rather
than to show information of all three cavitation modes on one single display, and a state-ofthe art display solution should be implemented, such as that suggested in [24].
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Spatio-temporal cavitation imaging also suffers from fundamental limitations. First, the poor
axial resolution precludes precise identification of the origin of the cavitation signals. For
example, microcirculation cavitation cannot be separated from cavitation from nearby major
arteries (or the heart chambers) because of signal smearing from these larger pools of
contrast microbubbles that probably contribute to most of the observed cavitation signals.
Shorter pulses yield better resolution but less robust cavitation states—because several
cycles of ultrasound are typically needed before stable cavitation can be observed—and
poorer spectral resolution. In our experience, the shortest pulse length at which
ultraharmonics have been confidently observed was 10 µ s (corresponding to an axial
resolution of 1.5 cm) [23]. Another reason why it is difficult to estimate microcirculation
cavitation in our study was that the time interval between frames did not allow for
replenishment of bubbles within the microcirculation (typically of the order of several
seconds). In sonothrombolysis for acute ischemic stroke treatment, the target is a blood clot
in a major artery of the brain (a few millimeters in diameter) and cavitation within those
vessels can probably be resolved, but further work is required to address cavitation
monitoring in the microcirculation.
Second, subtraction of consecutive pulses is necessary to eliminate tissue interference, but
results in nonlinear estimates of cavitation intensity. Also, the bubble signal is highly
variable from one frame to the next because there is a significantly new bubble population in
each frame at this low frame rate, and because of significant bubble destruction. The
resulting temporal discontinuities may be mitigated by higher frame-rate imaging or at lower
insonation pressures.
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Finally, the observed evolution of the backscattered spectra was more complicated than our
simplified hypothesis of three distinct cavitation modes separated by MI thresholds.
Through the skull, high levels of broadband electronic noise were present at very low MIs
because of low SNR resulting from high attenuation, yielding a false display of dominant
IC. In some situations, ultraharmonics were barely visible; in others there seemed to be two
successive ultraharmonic regimes (see, e.g., the nonattenuated in vitro experiment of Fig. 6
(top): ultraharmonics first are present with little background noise at MIs of 0.3 to 0.8, then
the ultraharmonics are indistinguishable from the noise from MIs of 0.8 to 1.0, and at higher
MIs, salient ultraharmonics appear again, this time concurrently with elevated noise. In the
green-yellow-red display, this shows as a pure yellow display (MIs 0.3 to 0.8), followed by
pure red (0.8 to 1.0) followed by a mix of yellow and red (1.0 and higher). It is also notable
that in most experiments the relative level of noise (with respect to the fundamental) starts to
increase at low MIs, then peaks and decreases at higher MIs. This may be indicative of a
faster destruction rate of the microbubbles, but it may also be an artifact resulting from the
tissue suppression part of the algorithms, in which the data from two consecutive pulses are
subtracted. It has also been observed that the second harmonic value (normalized to the
fundamental) tends to peak at about the value of the SC threshold, then decreases at higher
MIs. These observations pose fundamental questions about the physical mechanisms that are
the cause of the observed spectral patterns, presenting challenges to microbubble cavitation
imaging. It is likely that the analysis of the entire spectrum (and not only a few of its
features: ultraharmonics, second harmonics, and broadband noise strength, as presented
here) should be utilized for classifying dominant cavitation regimes.
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An ultrasound imaging system was modified to deliver sonothrombolysis pulses and
spatially and temporally monitor the dominant state and level of cavitation activity present
in a treatment area. Such a tool will be useful in advancing the understanding of cavitation
mechanisms in sonothrombolysis and other MB-mediated US therapies. It is hoped that this
tool will allow safe and effective thrombolysis treatment: cavitation imaging enables
treatment planning (estimating skull attenuation and compensating for it by adjusting the
output power) and monitoring (generating and updating 2-D cavitation maps).
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Fig. 1.

Sonothrombolysis (STL) pulse sequence. The STL pulses are sent as ensembles of 4 pulses
of the same length. Short B-mode pulses of lower amplitude are interleaved to generate a
background image of the anatomy.
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Fig. 2.

Block diagram of the cavitation imaging algorithm.
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Fig. 3.

Schematic of the setup for in vitro experiments.
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Fig. 4.

Cavitation images of a vessel phantom through a water path at mechanical indexes (MIs)
with dominant moderate oscillations (left), dominant stable cavitation (center), and
dominant inertial cavitation (right). The corresponding MIs are indicated, and the average
spectrum over the region of interest outlined in blue is displayed in logarithmic scale.
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Fig. 5.

Cavitation images of a vessel phantom through a human temporal bone sample at
mechanical indexes (MIs) with dominant moderate oscillations (left), dominant stable
cavitation (center), and dominant inertial cavitation (right). The corresponding MIs are
indicated, and the average spectrum over the region of interest outlined in blue is displayed
in logarithmic scale.
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Fig. 6.
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Averaged cavitation spectra (left) and cavitation doses (right) as a function of mechanical
index (MIs), through water without a temporal bone (top) and through a temporal bone
sample (bottom). Four measurements are taken at each MI. The spectra are averaged from
the regions of interest (within the blue boxes) of Figs. 4 and 5 and displayed in a decibel
scale (normalized to the fundamental frequency, 35 dB dynamic range). The cavitation
doses (dashed blue for ultraharmonic, red for noise) are spatially averaged from the ROIs
and displayed with error bars representing standard deviation over 4 measurements. The
thresholds for stable cavitation (the ultraharmonic dose exceeds the noise dose by at least 3
dB) are indicated as vertical dashed lines.
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Fig. 7.

Cavitation images of a porcine brain through the temporal acoustic window at mechanical
indexes (MIs) with dominant moderate oscillations (left), dominant stable cavitation
(center), and dominant inertial cavitation (right), and the corresponding averaged spectra
over the region of interest (inside the blue box). P = brain parenchyma, S = contralateral
skull.
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Fig. 8.

Cavitation images of a porcine heart (parasternal short-axis view of the left ventricle) at
mechanical indexes (MIs) with dominant moderate oscillations (left), dominant stable
cavitation (center), and dominant inertial cavitation (right), and the corresponding averaged
spectra over the region of interest. LV = left ventricle, M = myocardium.
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Fig. 9.

Cavitation images of a pig liver (subcostal view) at mechanical indexes (MIs) with dominant
moderate oscillations (left), dominant stable cavitation (center), and dominant inertial
cavitation (right), and the corresponding averaged spectra over the region of interest.
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Fig. 10.

Averaged cavitation spectra (left) and cavitation doses (right) as a function of mechanical
index (MIs) for the porcine brain (top), heart (middle), and liver (bottom). The same display
is used here as in Fig. 6. The stable cavitation threshold can be readily identified from
microbubbles within the heart chamber, but it is difficult to establish a threshold from the
brain and liver examinations.
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